Derivative Instruments |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Derivative Instruments | |
| Derivative Instruments | 7. Derivative Instruments
From time-to-time Solitario sold covered call options against its prior holdings of shares of common stock of Kinross Gold Corp. (“Kinross”) that were included in its marketable equity securities. The business purpose of selling covered calls was to provide additional income on a limited portion of shares of Kinross that Solitario may sell in the near term, which is generally defined as less than one year and any changes in the fair value of its covered calls are recognized in the statement of operations in the period of the change.
Solitario has no derivative instruments outstanding at June 30, 2026 and December 31, 2025. In August 2024, Solitario sold covered calls against its holdings of Kinross for net proceeds of $39,000. During the three and six months ended June 30, 2025, Solitario recorded a loss on derivative instruments of $130,000 and $336,000, respectively related to its Kinross calls. Solitario settled its Kinross calls in May 2025, upon the sale of its holdings of Kinross. |
| X | ||||||||||
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|